Kanagawa, Japan

Kumi Yamada


Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 12(Granted Patents)


Location History:

  • Kanagawa, JP (1995)
  • Yokohama, JP (1997)

Company Filing History:


Years Active: 1995-1997

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kumi Yamada: Innovator in Pharmaceutical Development

Introduction

Kumi Yamada is a prominent inventor based in Kanagawa, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of medicaments for treating various diseases. With a total of 2 patents to her name, Yamada's work is recognized for its innovative approaches to medical treatment.

Latest Patents

Yamada's latest patents include a medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia. This method involves administering a therapeutically or prophylactically effective amount of an aminopyridazine derivative or a salt thereof. Another notable patent is for a 3,6-disubstituted pyridazine derivative, which exhibits excellent platelet agglutination inhibitory effects. This compound is useful for preventive and therapeutic medicine for cerebrovascular disorders, ischemic heart diseases, and circulation disorders.

Career Highlights

Kumi Yamada is currently employed at Mitsubishi Chemical Corporation, where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in advancing medical treatments that address critical health issues.

Collaborations

Yamada collaborates with esteemed colleagues such as Yoshikuni Tamao and Norimichi Iwase, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kumi Yamada's contributions to pharmaceutical development highlight her role as a leading inventor in her field. Her innovative patents and collaborations reflect her commitment to improving health outcomes through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…